FIBRINOGEN RECEPTOR ANTAGONIST PRODRUGS - Patent 0912513

(19)

(11)

EP 0 912 513 A1

(12)

(43)	Date of publication:
	06.05.1999 Bulletin 1999/18

(21)	Application number: 97931401.0

(22)	Date of filing: 25.06.1997

(51)

International Patent Classification (IPC):

C07D 295/ 14^{( . )}
C07D 209/ 46^{( . )}
C07D 211/ 76^{( . )}
C07D 295/ 155^{( . )}
C07D 471/ 04^{( . )}

A61K 31/ 495^{( . )}
C07D 211/ 34^{( . )}
C07D 213/ 73^{( . )}
C07D 401/ 06^{( . )}
C07D 487/ 04^{( . )}

(86)	International application number:
	PCT/US1997/011047

(87)	International publication number:
	WO 1998/000401 (08.01.1998 Gazette 1998/01)

(84)	Designated Contracting States:
	AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

(30)

Priority:

28.06.1996 US 19960020877P
28.08.1996 GB 19960017899

(71)	Applicant: MERCK & CO., INC.
	Rahway, New Jersey 07065 (US)

(72)	Inventors:
	YOUNG, Steven, D. Rahway, NJ 07065 (US) HARTMAN, George, D. Rahway, NJ 07065 (US) LIBBY, Laura, A. Rahway, NJ 07065 (US) EGBERTSON, Melissa, S. Rahway, NJ 07065 (US) SLAUGHTER, Donald, E. Rahway, NJ 07065 (US)

(74)	Representative: Horgan, James Michael Frederic, et al
	Merck & Co., Inc., Terlings Park, Eastwick Road Harlow, Essex CM20 2QR Harlow, Essex CM20 2QR (GB)

(54)	FIBRINOGEN RECEPTOR ANTAGONIST PRODRUGS